Your search history is turned on.
Date: June 14, 2012 Jurisdictions: British Columbia
Microsoft Word - 5377113_1.DOC BC Form 51-509F1 Notice OTC Issuer Ceases to be an OTC Reporting Issuer This is the form required under section 4(1) of BC Instrument 51-509 Issuers Quoted in the U.S. Over-the-Counter Markets for an OTC issuer to give notice that it is no longer an OTC reporting issuer. The Issuer Name of Issuer: Upstream Biosciences In...
Date: June 1, 2012 Jurisdictions: British Columbia
Microsoft Word - 5338943_1.DOC UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 4, 2009 UPSTREAM BIOSCIENCES INC. (Exact name o...
Microsoft Word - Document4 ASSET SALE AGREEMENT THIS AGREEMENT is dated as of December 14, 2009 (the Effective Date) BETWEEN: PACIFIC PHARMA TECHNOLOGIES INC., a company with an office at Suite 200 1892 West Broadway Street, Vancouver, British Columbia V6J 1Y9 (the Vendor) AND: JTAT CONSULTING INC., a company with a business o...
Microsoft Word - Document3 RETURN TO TREASURY AGREEMENT THIS AGREEMENT made effective as of December 4, 2009 BETWEEN: UPSTREAM BIOSCIENCES INC., a Nevada company having its office at Suite 200 1892 West Broadway, Vancouver, British Columbia, Canada V6J 1Y9 (the Company) AND: DEXSTER SMITH of c/o Suite 200 1892 West Broadway, V...
Microsoft Word - Document2 RETURN TO TREASURY AGREEMENT THIS AGREEMENT made effective as of December 4, 2009 BETWEEN: UPSTREAM BIOSCIENCES INC., a Nevada company having its office at Suite 200 1892 West Broadway, Vancouver, British Columbia, Canada V6J 1Y9 (the Company) AND: JOEL BELLENSON of c/o Suite 200 1892 West Broadway, Vanco...
Microsoft Word - 5338905_1.DOC UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 15, 2012 UPSTREAM BIOSCIENCES INC. (Exact name of registrant as specified in ...
Microsoft Word - 5338926_1.DOC UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 12, 2010 UPSTREAM BIOSCIENCES INC. (Exact name of registrant as specifi...
Date: May 30, 2012 Jurisdictions: British Columbia
Microsoft Word - 5324607_1.DOC Amended and Restated UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2010 TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF T...